COGT R&D to Revenue
Cogent Biosciences Inc · R&D to Revenue
COGT R&D to Revenue
Latest reported0.00%period ending
COGT FY R&D/Revenue (229.47% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
COGT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 922.9831% | |
| 194.2709% | |
| 393.3121% | |
| 356.8421% | |
| 346.0582% | |
| 229.4709% |